Fingerprint
Dive into the research topics of 'A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically